Literature DB >> 29384802

Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Rachel C Nolan1, Steven L Galetta, Teresa C Frohman, Elliot M Frohman, Peter A Calabresi, Carmen Castrillo-Viguera, Diego Cadavid, Laura J Balcer.   

Abstract

BACKGROUND: The optic nerve is a frequent site for involvement in multiple sclerosis (MS). Optical coherence tomography (OCT) detects thinning of the retinal nerve fiber layer (RNFL) in eyes of patients with MS and in those meeting criteria for clinically or radiologically isolated demyelinating syndromes. Current international diagnostic criteria for MS do not include the optic nerve as an imaging lesion site despite the high prevalence of acute optic neuritis (ON), or occult optic neuropathy, among early MS and clinically isolated syndrome patients; as well as most MS patients over the course of the disease. We sought to determine optimal thresholds for intereye difference in peripapillary RNFL thickness that are most predictive of a unilateral optic nerve lesion.
METHODS: We analyzed spectral domain OCT data of 31 healthy volunteers and 124 patients with MS at a single center as part of an ongoing collaborative investigation of visual outcomes. Intereye differences in peripapillary (360°) RNFL thickness were calculated as the absolute value of the difference. First, we determined the 95th percentile value of intereye difference for the healthy volunteers. This value was applied to the convenience sample group of MS patients as a validation cohort determining how well this threshold could distinguish patients with vs without a history of unilateral ON. The relation of intereye differences in peripapillary RNFL thickness to binocular low-contrast letter acuity scores was also examined.
RESULTS: Among healthy volunteer participants (n = 31), the 95th percentile value for intereye difference (upper boundary of expected for normal controls) was 6.0 μm. This value was applied to the convenience sample group of MS patients (n = 124, validation cohort). Positive predictive value, negative predictive value, sensitivity, and specificity for identifying MS patients with a history of unilateral ON were calculated for the 6-μm threshold value in a 2 × 2 table analysis with the application of χ tests (P < 0.0001). The 6-μm threshold was predictive of worse binocular low-contrast acuity scores at 2.5% (P = 0.03) and 1.25% (P = 0.002 by linear regression analyses). A receiver operating characteristic curve analysis demonstrated an optimal intereye difference threshold of 5 μm for identifying unilateral ON in the MS cohort.
CONCLUSIONS: An intereye difference of 5-6 μm in RNFL thickness is a robust structural threshold for identifying the presence of a unilateral optic nerve lesion in MS.

Entities:  

Mesh:

Year:  2018        PMID: 29384802      PMCID: PMC8845082          DOI: 10.1097/WNO.0000000000000629

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  56 in total

Review 1.  Clinical practice. Optic neuritis.

Authors:  Laura J Balcer
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

2.  Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes.

Authors:  Fiona Costello; William Hodge; Y Irene Pan; Mark Freedman; Christine DeMeulemeester
Journal:  J Neurol Sci       Date:  2009-03-20       Impact factor: 3.181

3.  Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?

Authors:  Giovanni Di Maggio; Roberto Santangelo; Simone Guerrieri; Mariangela Bianco; Laura Ferrari; Stefania Medaglini; Mariaemma Rodegher; Bruno Colombo; Lucia Moiola; Raffaella Chieffo; Ubaldo Del Carro; Vittorio Martinelli; Giancarlo Comi; Letizia Leocani
Journal:  Mult Scler       Date:  2014-03-03       Impact factor: 6.312

Review 4.  The neuro-ophthalmology of multiple sclerosis.

Authors:  Elliot M Frohman; Teresa C Frohman; David S Zee; Roderick McColl; Steven Galetta
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

5.  Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

Authors:  M L Baier; G R Cutter; R A Rudick; D Miller; J A Cohen; B Weinstock-Guttman; M Mass; L J Balcer
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

6.  Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.

Authors:  Diego Cadavid; Laura Balcer; Steven Galetta; Orhan Aktas; Tjalf Ziemssen; Ludo Vanopdenbosch; Jette Frederiksen; Mark Skeen; Glenn J Jaffe; Helmut Butzkueven; Focke Ziemssen; Luca Massacesi; Yi Chai; Lei Xu; Stefanie Freeman
Journal:  Lancet Neurol       Date:  2017-02-15       Impact factor: 44.182

7.  Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis.

Authors:  J Toledo; J Sepulcre; A Salinas-Alaman; A García-Layana; M Murie-Fernandez; B Bejarano; P Villoslada
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

8.  Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.

Authors:  Raed Behbehani; Abdullah Abu Al-Hassan; Abdullah Al-Khars; Devarajan Sriraman; Raed Alroughani
Journal:  J Neurol Sci       Date:  2015-11-10       Impact factor: 3.181

9.  Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity.

Authors:  E M Mowry; M J Loguidice; A B Daniels; D A Jacobs; C E Markowitz; S L Galetta; M L Nano-Schiavi; G R Cutter; M G Maguire; L J Balcer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-23       Impact factor: 10.154

10.  Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes.

Authors:  Jeffrey M Gelfand; Douglas S Goodin; W John Boscardin; Rachel Nolan; Ami Cuneo; Ari J Green
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

View more
  17 in total

1.  The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.

Authors:  Rachel C Kenney; Mengling Liu; Lisena Hasanaj; Binu Joseph; Abdullah Abu Al-Hassan; Lisanne J Balk; Raed Behbehani; Alexander Brandt; Peter A Calabresi; Elliot Frohman; Teresa C Frohman; Joachim Havla; Bernhard Hemmer; Hong Jiang; Benjamin Knier; Thomas Korn; Letizia Leocani; Elena Hernandez Martinez-Lapiscina; Athina Papadopoulou; Friedemann Paul; Axel Petzold; Marco Pisa; Pablo Villoslada; Hanna Zimmermann; Lorna E Thorpe; Hiroshi Ishikawa; Joel S Schuman; Gadi Wollstein; Yu Chen; Shiv Saidha; Steven Galetta; Laura J Balcer
Journal:  Neurology       Date:  2022-06-28       Impact factor: 11.800

Review 2.  Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Rachel C Nolan; Omar Akhand; John-Ross Rizzo; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-06       Impact factor: 3.042

3.  Focal alteration of the intraretinal layers in neurodegenerative disorders.

Authors:  Shriya Airen; Ce Shi; Zhiping Liu; Bonnie E Levin; Joseph F Signorile; Jianhua Wang; Hong Jiang
Journal:  Ann Eye Sci       Date:  2020-03

Review 4.  The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis.

Authors:  Laura J Balcer; Lisanne J Balk; Alexander U Brandt; Peter A Calabresi; Elena H Martinez-Lapiscina; Rachel C Nolan; Friedemann Paul; Axel Petzold; Shiv Saidha
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

Review 5.  Advances in ophthalmic structural and functional measures in multiple sclerosis: do the potential ocular biomarkers meet the unmet needs?

Authors:  Hong Jiang; Silvia Delgado; Jianhua Wang
Journal:  Curr Opin Neurol       Date:  2021-02-01       Impact factor: 6.283

6.  Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis.

Authors:  Vittorio Mantero; Lucia Abate; Roberto Balgera; Loredana La Mantia; Andrea Salmaggi
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

7.  The astrocyte transcriptome in EAE optic neuritis shows complement activation and reveals a sex difference in astrocytic C3 expression.

Authors:  Alessia Tassoni; Vista Farkhondeh; Yuichiro Itoh; Noriko Itoh; Michael V Sofroniew; Rhonda R Voskuhl
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379

8.  Retinal measurements predict 10-year disability in multiple sclerosis.

Authors:  Alissa Rothman; Olwen C Murphy; Kathryn C Fitzgerald; Julia Button; Eliza Gordon-Lipkin; John N Ratchford; Scott D Newsome; Ellen M Mowry; Elias S Sotirchos; Stephanie B Syc-Mazurek; James Nguyen; Natalia Gonzalez Caldito; Laura J Balcer; Elliot M Frohman; Teresa C Frohman; Daniel S Reich; Ciprian Crainiceanu; Shiv Saidha; Peter A Calabresi
Journal:  Ann Clin Transl Neurol       Date:  2019-01-19       Impact factor: 4.511

9.  Focal Thickness Reduction of the Ganglion Cell-Inner Plexiform Layer Best Discriminates Prior Optic Neuritis in Patients With Multiple Sclerosis.

Authors:  Huiling Hu; Hong Jiang; Giovana Rosa Gameiro; Jeffrey Hernandez; Silvia Delgado; Jianhua Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.799

10.  Predictors of response to opicinumab in acute optic neuritis.

Authors:  Diego Cadavid; Laura Balcer; Steven Galetta; Orhan Aktas; Tjalf Ziemssen; Ludo J Vanopdenbosch; Letizia Leocani; Mark S Freedman; Gordon T Plant; Jana Lizrova Preiningerova; Focke Ziemssen; Luca Massacesi; Yi Chai; Lei Xu
Journal:  Ann Clin Transl Neurol       Date:  2018-08-15       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.